Barinthus Biotherapeutics (BRNS) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
Barinthus Biotherapeutics (BRNS) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.78 Mn | -39.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.16% |
| Dec 31, 2025 | 23.80% |
| Sep 30, 2025 | 31.03% |
| Jun 30, 2025 | -7.47% |
| Mar 31, 2025 | 4.53% |
| Dec 31, 2024 | -153.30% |
| Sep 30, 2024 | 52.02% |
| Jun 30, 2024 | -9.17% |
| Mar 31, 2024 | 10.24% |
| Dec 31, 2023 | -22.54% |
| Sep 30, 2023 | 40.77% |
| Jun 30, 2023 | -30.74% |
| Mar 31, 2023 | 13.89% |
| Dec 31, 2022 | -357.43% |
| Sep 30, 2022 | -47.60% |
| Jun 30, 2022 | 509.52% |
| Mar 31, 2022 | 115.40% |
| Dec 31, 2021 | -202.37% |
| Sep 30, 2021 | 67.20% |
| Jun 30, 2021 | -92.54% |